294 related articles for article (PubMed ID: 11785354)
1. [Antenatal anti-Rh(D) antigen prophylaxis].
Katsulov A;
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
[No Abstract] [Full Text] [Related]
2. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
[No Abstract] [Full Text] [Related]
3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
4. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.
Jones ML; Wray J; Wight J; Chilcott J; Forman K; Tappenden P; Beverley C
BJOG; 2004 Sep; 111(9):892-902. PubMed ID: 15327601
[No Abstract] [Full Text] [Related]
5. Rhesus isoimmunization.
Plevyak MP; Carr SR
Med Health R I; 2001 May; 84(5):148-51. PubMed ID: 11392951
[TBL] [Abstract][Full Text] [Related]
6. Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme.
Mayne S; Parker JH; Harden TA; Dodds SD; Beale JA
BMJ; 1997 Dec; 315(7122):1588. PubMed ID: 9437277
[No Abstract] [Full Text] [Related]
7. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
[No Abstract] [Full Text] [Related]
8. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
9. Anti-D immunoglobulin prophylaxis--are we doing enough?
Drug Ther Bull; 1985 Dec; 23(24):93-5. PubMed ID: 2998720
[No Abstract] [Full Text] [Related]
10. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
McFadyen IR; Martlew VJ; Howard HL; Clarke CA
BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
[No Abstract] [Full Text] [Related]
11. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
Craig JS; McClure BG; Tubman TR
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
[No Abstract] [Full Text] [Related]
12. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
13. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
14. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997.
Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199
[No Abstract] [Full Text] [Related]
15. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
Hannafin B; Lovecchio F; Blackburn P
Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
[TBL] [Abstract][Full Text] [Related]
16. Rh-immunoglobulin: Rh prophylaxis.
Bowman J
Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
[No Abstract] [Full Text] [Related]
17. Anti-D guidelines.
Kanjilal K; Tasker M
Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
[No Abstract] [Full Text] [Related]
18. [Comparison of the efficacy of different methods for the prevention of anti-D allo-immunization during pregnancy: targeted strategy limited to risk situations or associated with systematic prevention in the 3rd trimester].
Parant O
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S93-1S103. PubMed ID: 16495834
[TBL] [Abstract][Full Text] [Related]
19. [Biological markers: what changes with prophylaxis?].
Mannessier L
J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S9-11. PubMed ID: 18228706
[No Abstract] [Full Text] [Related]
20. Cochrane made simple. Anti-D administration during pregnancy for preventing Rhesus isoimmunisation.
Anderson T
Pract Midwife; 1999 Jun; 2(6):10. PubMed ID: 10481667
[No Abstract] [Full Text] [Related]
[Next] [New Search]